Video: Mark Miller of Lilly on #RareDisease and licensing

In Clinical Trials by caroline hornbyLeave a Comment

Mark Miller of Lilly on orphan drugs and licensing Mark Miller, Vice President, Corporate Business Development, Lilly, presented at last year's World Orphan Drug Congress USA on the topic ‘Leveraging licensing and acquisitions to enter orphan disease research successfully.'

Do you want to learn more about:

  • Interest in orphan diseases and vision of the future
  • Challenges that need to be overcome
  • Strategy for entering the orphan disease area and implementing strategy

If so, you need to check out the video below:

For more information on orphan drugs and rare diseases, check out the World Orphan Drug Congress USA. Remember, the earlier you book, the more you save, so register now to secure your seat!

Leave a Comment

Current ye@r *